XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Business Segments
9 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Business Segments Business Segments
Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses.

The tables below summarize information about our reportable segments.
 Three Months Ended December 31, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$236,565 $46,176 $282,741 
Cost of sales106,090 18,713 124,803 
Gross profit130,475 27,463 157,938 
Advertising and marketing33,917 5,549 39,466 
Contribution margin$96,558 $21,914 $118,472 
Other operating expenses 31,640 
Operating income $86,832 
* Intersegment revenues of $0.5 million were eliminated from the North American OTC Healthcare segment.

 Nine Months Ended December 31, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$727,131 $121,235 $848,366 
Cost of sales323,632 52,103 375,735 
Gross profit403,499 69,132 472,631 
Advertising and marketing100,707 15,092 115,799 
Contribution margin$302,792 $54,040 $356,832 
Other operating expenses 96,556 
Operating income $260,276 
* Intersegment revenues of $2.5 million were eliminated from the North American OTC Healthcare segment.


 Three Months Ended December 31, 2022
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$236,884 $38,640 $275,524 
Cost of sales110,554 14,568 125,122 
Gross profit 126,330 24,072 150,402 
Advertising and marketing24,831 5,592 30,423 
Contribution margin$101,499 $18,480 $119,979 
Other operating expenses 32,795 
Operating income $87,184 
* Intersegment revenues of $1.1 million were eliminated from the North American OTC Healthcare segment.
 Nine Months Ended December 31, 2022
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Total segment revenues*$731,456 $110,400 $841,856 
Cost of sales327,008 43,318 370,326 
Gross profit 404,448 67,082 471,530 
Advertising and marketing99,559 14,634 114,193 
Contribution margin$304,889 $52,448 $357,337 
Other operating expenses 98,755 
Operating income $258,582 
* Intersegment revenues of $2.8 million were eliminated from the North American OTC Healthcare segment.



The tables below summarize information about our segment revenues from similar product groups.
Three Months Ended December 31, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$28,680 $1,586 $30,266 
Cough & Cold27,359 5,814 33,173 
Women's Health53,076 5,190 58,266 
Gastrointestinal38,919 22,707 61,626 
Eye & Ear Care38,503 6,569 45,072 
Dermatologicals26,603 1,165 27,768 
Oral Care20,362 3,100 23,462 
Other OTC3,063 45 3,108 
Total segment revenues$236,565 $46,176 $282,741 
Nine Months Ended December 31, 2023
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$85,838 $3,814 $89,652 
Cough & Cold73,703 19,129 92,832 
Women's Health163,031 17,218 180,249 
Gastrointestinal122,303 49,678 171,981 
Eye & Ear Care117,719 17,715 135,434 
Dermatologicals94,299 3,972 98,271 
Oral Care61,400 9,591 70,991 
Other OTC8,838 118 8,956 
Total segment revenues$727,131 $121,235 $848,366 
Three Months Ended December 31, 2022
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$29,396 $648 $30,044 
Cough & Cold31,246 6,336 37,582 
Women's Health53,918 4,138 58,056 
Gastrointestinal38,194 18,555 56,749 
Eye & Ear Care32,653 5,229 37,882 
Dermatologicals27,223 978 28,201 
Oral Care21,371 2,738 24,109 
Other OTC2,883 18 2,901 
Total segment revenues$236,884 $38,640 $275,524 
Nine Months Ended December 31, 2022
(In thousands)North American OTC
Healthcare
International OTC
Healthcare
Consolidated
Analgesics$89,943 $1,642 $91,585 
Cough & Cold76,896 19,775 96,671 
Women's Health174,481 13,750 188,231 
Gastrointestinal119,533 48,619 168,152 
Eye & Ear Care109,225 14,699 123,924 
Dermatologicals89,550 2,886 92,436 
Oral Care63,597 8,988 72,585 
Other OTC8,231 41 8,272 
Total segment revenues$731,456 $110,400 $841,856